Peptide receptor radionuclide therapy

This publication has 43 references indexed in Scilit:

• Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
  Journal of Clinical Oncology, 2005
• Peptidrezeptorvermittelte Radiotherapie (PRRT) neuroendokriner Tumoren
  Der Onkologe, 2004
• Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues
  Nephrology Dialysis Transplantation, 2004
• Quality of Life in Patients With Gastroenteropancreatic Tumors Treated With [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate
  Journal of Clinical Oncology, 2004
• Assessment of Hepatic Toxicity from Treatment with ⁹⁰Y-SMT 487 (OctreoTher™) in Patients with Diffuse Somatostatin Receptor Positive Liver Metastases
  Cancer Biotherapy & Radiopharmaceuticals, 2003
• Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
  Seminars in Nuclear Medicine, 2002
• ⁹⁰Y–DOTA–D‐Phe¹–Try³– octreotide in therapy of neuroendocrine malignancies
  Peptide Science, 2002
• Cloning, Functional Expression and Pharmacological Characterization of a Fourth (hSSTR4) and a Fifth (hSSTR5) Human Somatostatin Receptor Subtype
  Biochemical and Biophysical Research Communications, 1993
• Somatostatin Receptors: Orphan That Found Family and Function
  Molecular and Cellular Neuroscience, 1993
• In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats
  Life Sciences, 1991